Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Assessment of NO Mediated Signaling in Cancer Cachexia

NCT02106871 is registered in ClinicalTrials.gov with The University of Texas Medical Branch, Galveston as lead sponsor.

NCT NCT02106871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02106871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Assessment of NO Mediated Signaling in Cancer Cachexia
Lead sponsor
The University of Texas Medical Branch, Galveston
Phase
Phase 1
Overall status
Withdrawn
Start date
April 30, 2014
Completion date
June 30, 2017
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma, pancreatic cancer